MyFinsight
Home
Blog
About
Property and equipment,
gross
$16,220,275
(39.74%↑ Y/Y)
Prepaid expense and
other current assets
$151,559
(-22.28%↓ Y/Y)
Due from related
parties
$136,344
(-90.41%↓ Y/Y)
Short-term investments
$62,420
(-4.28%↓ Y/Y)
Cash and cash
equivalents
$31,944
(-91.77%↓ Y/Y)
Convertible notes
receivable related parties
$29,462
Property and equipment,
net
$12,831,939
(56.19%↑ Y/Y)
Long-term investments
$2,489,697
(-12.27%↓ Y/Y)
Operating lease
right-of-use assets
$1,743,926
(279.67%↑ Y/Y)
Prepayment for long-term
investments
$1,124,842
(0.00%↑ Y/Y)
Prepayment for asset
acquisition
$691,900
(0.00%↑ Y/Y)
Total current assets
$411,729
(-85.14%↓ Y/Y)
Other non-current
assets
$106,682
(-24.50%↓ Y/Y)
Less accumulated
depreciation
$3,388,336
(-0.10%↓ Y/Y)
Total assets
$19,400,715
(19.45%↑ Y/Y)
Total liabilities and
equity
$19,400,715
(19.45%↑ Y/Y)
Total equity
$12,269,560
(29.29%↑ Y/Y)
Total liabilities
$7,131,155
(5.63%↑ Y/Y)
Total stockholders
equity
$10,287,183
(46.67%↑ Y/Y)
Noncontrolling interest
$1,982,377
(-19.94%↓ Y/Y)
Total current
liabilities
$5,694,505
(-12.83%↓ Y/Y)
Operating lease liability
non-current
$1,405,483
(693.46%↑ Y/Y)
Tenant security
deposit
$31,167
(-25.22%↓ Y/Y)
Accumulated deficit
-$79,155,537
(-9.86%↓ Y/Y)
Treasury stock
$8,909,691
(0.00%↑ Y/Y)
Additional paid-in capital
$97,722,998
(13.13%↑ Y/Y)
Accrued expenses and
other current...
$4,200,027
(-2.12%↓ Y/Y)
Convertible notes payable
third parties-Third...
$559,010
Operating lease
liabilities
$358,107
(26.90%↑ Y/Y)
Due to related
parties-Related Party
$265,299
Convertible notes payable
related...
$240,000
Short-term bank and other
loans
$59,462
(-93.18%↓ Y/Y)
Contract liabilities
$12,600
(-84.47%↓ Y/Y)
Accumulated other
comprehensive income
$498,193
(2.97%↑ Y/Y)
Stock to be issued
$105,000
(-90.37%↓ Y/Y)
Common stock, 0.001 par
value, 100,000,000...
$26,220
(34.23%↑ Y/Y)
Back
Back
Balance Sheet
ABVC BIOPHARMA, INC. (ABVC)
ABVC BIOPHARMA, INC. (ABVC)
source: myfinsight.com